On Monday, Ventyx Biosciences' CEO AND PRESIDENT, Raju Mohan, made a $959,889 purchase of VTYX, buying 500,000 shares at a cost of $1.92 each. Mohan was up about 24.0% on the buy at the high point of today's trading session, with VTYX trading as high as $2.38 at last check today. Ventyx Biosciences is trading up about 14.8% on the day Tuesday. This buy marks the first one filed by Mohan in the past year.
And at Neurogene, there was insider buying on Friday, by CFO Christine Mikail Cvijic who bought 24,000 shares at a cost of $20.48 each, for a trade totaling $491,400. This purchase marks the first one filed by Cvijic in the past year. Neurogene is trading up about 14% on the day Tuesday. Cvijic was up about 31.1% on the purchase at the high point of today's trading session, with NGNE trading as high as $26.85 at last check today.
https://www.nasdaq.com/articles/tuesday-11-26-insider-buying-report-vtyx-ngne
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.